These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 26030250)

  • 21. Prevalence of Warfarin Genotype Polymorphisms in Patients with Mechanical Circulatory Support.
    Awad M; Czer LS; Soliman C; Mirocha J; Ruzza A; Pinzas J; Rihbany K; Chang D; Moriguchi J; Ramzy D; Esmailian F; Kobashigawa J; Arabia F
    ASAIO J; 2015; 61(4):391-6. PubMed ID: 26125664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel high-speed droplet-allele specific-polymerase chain reaction: application in the rapid genotyping of single nucleotide polymorphisms.
    Taira C; Matsuda K; Yamaguchi A; Sueki A; Koeda H; Takagi F; Kobayashi Y; Sugano M; Honda T
    Clin Chim Acta; 2013 Sep; 424():39-46. PubMed ID: 23685227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy.
    Shaw K; Amstutz U; Kim RB; Lesko LJ; Turgeon J; Michaud V; Hwang S; Ito S; Ross C; Carleton BC;
    Ther Drug Monit; 2015 Aug; 37(4):428-36. PubMed ID: 26186657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between CYP2C9 and VKORC1 genetic polymorphism and warfarin dose requirements].
    Yang J; Miao LY; Huang CR; Shen ZY; Jiang WP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):137-40. PubMed ID: 19099951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.
    Namazi S; Azarpira N; Hendijani F; Khorshid MB; Vessal G; Mehdipour AR
    Clin Ther; 2010 Jun; 32(6):1050-60. PubMed ID: 20637959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of CYP2C9 and VKORC1 genetic polymorphisms on mean daily maintenance dose of acenocoumarol in South Indian patients.
    Krishna Kumar D; Madhan S; Balachander J; Sai Chandran BV; Thamijarassy B; Adithan C
    Thromb Res; 2013 Apr; 131(4):363-7. PubMed ID: 23473641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement.
    Schalekamp T; Brassé BP; Roijers JF; van Meegen E; van der Meer FJ; van Wijk EM; Egberts AC; de Boer A
    Clin Pharmacol Ther; 2007 Feb; 81(2):185-93. PubMed ID: 17192772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the Progenika ID CORE XT: an automated genotyping platform based on a fluidic microarray system.
    Goldman M; Núria N; Castilho LM
    Immunohematology; 2015; 31(2):62-8. PubMed ID: 26495891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation.
    Schalekamp T; Brassé BP; Roijers JF; Chahid Y; van Geest-Daalderop JH; de Vries-Goldschmeding H; van Wijk EM; Egberts AC; de Boer A
    Clin Pharmacol Ther; 2006 Jul; 80(1):13-22. PubMed ID: 16815313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke.
    Supe S; Božina N; Matijević V; Bazina A; Mišmaš A; Ljevak J; Alvir D; Habek M; Poljaković Z
    J Neurol Sci; 2014 Aug; 343(1-2):30-5. PubMed ID: 24974237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.
    Ye C; Jin H; Zhang R; Sun Y; Wang Z; Sun W; Sun W; Peng Q; Liu R; Huang Y
    J Int Med Res; 2014 Feb; 42(1):67-76. PubMed ID: 24287930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New allele-specific real-time PCR system for warfarin dose genotyping equipped with an automatic interpretative function that allows rapid, accurate, and user-friendly reporting in clinical laboratories.
    Kim S; Lee HW; Lee W; Um TH; Cho CR; Chun S; Min WK
    Thromb Res; 2012 Jul; 130(1):104-9. PubMed ID: 21911247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-based dosage of acenocoumarol in highly-sensitive geriatric patients.
    Lozano R; Franco ME; López L; Moneva JJ; Carrasco V; Pérez-Layo MA
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):206-10. PubMed ID: 25669612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-guided coumarin dosing: where are we now and where do we need to go next?
    Baranova EV; Verhoef TI; Asselbergs FW; de Boer A; Maitland-van der Zee AH
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):509-22. PubMed ID: 25595525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.
    Ortak H; Söğüt E; Demir H; Ardagil A; Benli I; Sahin S
    Clin Exp Ophthalmol; 2012; 40(7):743-8. PubMed ID: 22394334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extremely low warfarin dose in patients with genotypes of CYP2C9*3/*3 and VKORC1-1639A/A.
    Gao L; He L; Luo J; Xu B; Yang J; Zhang YX; Yang T; Li K; Tian JW; Wang HJ; Zhao YS; Lu CY; Zhang WZ; Yin T
    Chin Med J (Engl); 2011 Sep; 124(17):2767-70. PubMed ID: 22040439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Konovalova NV; Postnov AIu; Kirienko AI
    Ter Arkh; 2011; 83(6):59-65. PubMed ID: 21786578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and direct detection of apolipoprotein E genotypes using whole blood from humans.
    Kim SW; Heo JH; Kim CH; Yoo DC; Won DH; Lee SG; Cho KJ; Song JH; Park SJ; Yang YG; Choi DW
    J Toxicol Environ Health A; 2010; 73(21-22):1502-10. PubMed ID: 20954076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping.
    Maurice CB; Barua PK; Simses D; Smith P; Howe JG; Stack G
    Clin Chim Acta; 2010 Jul; 411(13-14):947-54. PubMed ID: 20226775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array™ System for simplified amplicon library preparation.
    Moonsamy PV; Williams T; Bonella P; Holcomb CL; Höglund BN; Hillman G; Goodridge D; Turenchalk GS; Blake LA; Daigle DA; Simen BB; Hamilton A; May AP; Erlich HA
    Tissue Antigens; 2013 Mar; 81(3):141-9. PubMed ID: 23398507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.